Artelo Biosciences

+$0.0061 (+1.86%) Today
+$0.0079 (+2.37%) As of 9:54 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARTL and other ETFs, options, and stocks.

About ARTL

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal.

CEO
Gregory D. Gorgas
Employees
5
Headquarters
Solana Beach, California
Founded
2011

ARTL Key Statistics

Market cap
14.12M
Price-Earnings ratio
—
Dividend yield
—
Average volume
284.36K
High today
$0.3418
Low today
$0.3277
Open price
$0.33
Volume
255.95K
52 Week high
$1.33
52 Week low
$0.30

ARTL Earnings

-$0.38
-$0.25
-$0.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
-$0.07 per share
Actual
-$0.05 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure